Brijeshkumar Patel

ORCID: 0000-0002-7378-1202
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inhalation and Respiratory Drug Delivery
  • Asthma and respiratory diseases
  • Pulmonary Hypertension Research and Treatments
  • Advanced Drug Delivery Systems
  • 3D Printing in Biomedical Research
  • Nanoparticle-Based Drug Delivery
  • Electrospun Nanofibers in Biomedical Applications
  • Lipid metabolism and disorders
  • Drug Solubulity and Delivery Systems
  • Tissue Engineering and Regenerative Medicine
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Glaucoma and retinal disorders
  • Erythrocyte Function and Pathophysiology
  • Sepsis Diagnosis and Treatment
  • Allergic Rhinitis and Sensitization
  • Peroxisome Proliferator-Activated Receptors
  • Extracellular vesicles in disease
  • Immune responses and vaccinations
  • Microfluidic and Bio-sensing Technologies
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Air Quality Monitoring and Forecasting
  • Pharmacological Effects and Assays
  • Neuroscience of respiration and sleep
  • Occupational exposure and asthma
  • PI3K/AKT/mTOR signaling in cancer

Texas Tech University Health Sciences Center
2012-2024

Texas Tech University
2012-2024

Regeneron (United States)
2021-2022

Smt. N.H.L. Municipal Medical College
2019

CHI Health Creighton University Medical Center - Bergan Mercy
2009

Kavita Praveen Gaurang Patel Lauren Gurski Ariane Ayer Trikaladarshi Persaud and 95 more Matthew Still Lawrence Miloscio Tavé van Zyl Silvio Alessandro Di Gioia Ben Brumpton Kristi Krebs Bjørn Olav Åsvold Esteban Chen Venkata Ramana Murthy Chavali Wen Fury Harini V. Gudiseva Sarah Hyde Eric Jorgenson Stéphanie Lefebvre Dadong Li Alexander Li James Mclninch Brijeshkumar Patel Jeremy S. Rabinowitz Rebecca Salowe Claudia Schurmann Anne-Sofie Seidelin Eli A. Stahl Dylan Sun Tanya M. Teslovich Anne Tybjærg‐Hansen Cristen J. Willer Scott Waldron Sabrina Walley Hua Yang Sarthak Zaveri Gonçalo R. Abecasis Michael Cantor Andrew Deubler Aris N. Economides Luca A. Lotta John D. Overton Jeffrey G. Reid Alan R. Shuldiner Katherine Siminovitch Christina Beechert Caitlin Forsythe Erin D. Fuller Zhenhua Gu Michael Lattari Alexander Lopez Thomas D. Schleicher Maria Sotiropoulos Padilla Louis Widom Sarah E. Wolf Manasi Pradhan Kia Manoochehri Ricardo H. Ulloa Xiaodong Bai Suganthi Balasubramanian Suying Bao Boris Boutkov Siying Chen Gisu Eom Lukas Habegger Alicia Hawes Shareef Khalid Olga Krasheninina Rouel Lanche Adam J. Mansfield Evan K. Maxwell Mona Nafde Sean O’Keeffe Max Orelus Razvan Panea Tommy Polanco Ayesha Rasool William Salerno Kathie Sun Amelia Averitt Nilanjana Banerjee Sameer Malhotra Deepika Sharma Jeffery C. Staples Ashish Yadav Joshua Backman Amy Damask Lee Dobbyn Manuel Allen Revez Ferreira Arkopravo Ghosh Christopher E. Gillies Hyun Min Kang Michael D. Kessler Jack A. Kosmicki Nan Lin Daren Liu Adam E. Locke Jonathan Marchini Anthony Marcketta Joelle Mbatchou

Glaucoma is a leading cause of blindness. Current glaucoma medications work by lowering intraocular pressure (IOP), risk factor for glaucoma, but most treatments do not directly target the pathological changes to increased IOP, which can manifest as medication resistance disease progresses. To identify physiological modulators we performed genome- and exome-wide association analysis in >129,000 individuals with IOP measurements extended these findings an risk. We report identification...

10.1038/s42003-022-03932-6 article EN cc-by Communications Biology 2022-10-03

Development of lung models for testing a drug substance or delivery system has been an intensive area research. However, model that mimics physiological and anatomical features human lungs is yet to be established. Although in vitro models, developed fine-tuned over the past few decades, were instrumental development many commercially available drugs, they are suboptimal reproducing microenvironment complex anatomy lungs. Similarly, intersubject variability high costs have major limitations...

10.1152/ajplung.00076.2012 article EN AJP Lung Cellular and Molecular Physiology 2012-08-12

Heparin-like compounds interrupt leukocyte adhesion and migration, prevent release of chemical mediators during the process inflammation. However, little is known whether anti-inflammatory property smaller heparin fragments, low-molecular-weight (LMWH), plays any role in airway In this study, we sought to evaluate efficacy LMWH-loaded large porous polyethylene glycol-poly(D,L-lactide-co-glycolide) (PEG-PLGA) particulate formulations alleviating cellular biochemical changes associated with...

10.1089/jamp.2013.1073 article EN Journal of Aerosol Medicine and Pulmonary Drug Delivery 2013-11-28

Objectives: To determine the discriminative ability of PRISM III scoring system in predicting mortality children admitted to PICU.Methods: Prospective observational study all 1 month 12 years age PICU during July2017 June2018.Result: Out 250 patients PICU, 133 were male & 117 female. In group months, 30(22.22%) expired while months years,18(11.65%) expired. Due respiratory involvement, was 24(16.43%), due central nervous 8(17.39%) and septicemia 12(46.15%) . At hours admission, 214 had score...

10.21304/2019.0603.00499 article EN cc-by-nc-sa JOURNAL OF PEDIATRIC CRITICAL CARE 2019-01-01

Abstract Glaucoma is a leading cause of blindness. Current glaucoma medications work by lowering intraocular pressure (IOP), risk factor for glaucoma, but most treatments do not directly target the pathological changes to increased IOP, which can manifest as medication resistance disease progresses. To identify physiological modulators we performed genome- and exome-wide association analysis in >129,000 individuals with IOP measurements extended these findings an risk. We report...

10.21203/rs.3.rs-858876/v1 preprint EN cc-by Research Square (Research Square) 2021-09-08
Coming Soon ...